案件背景 - 罗森律师事务所提醒在2024年2月7日至2024年11月24日期间购买Cassava Sciences公司证券的投资者注意2025年2月10日的首席原告截止日期 [1] - 投资者可能有权通过应急费用安排获得赔偿而无需支付任何自付费用 [2] 诉讼详情 - 诉讼指控被告在诉讼期间制造了关于Cassava药物前景和预期增长的虚假印象 同时淡化了药物失败的风险 [5] - 实际上 Cassava对其主要候选药物simufilam的信心和对第二阶段研究统计上不显著数据的依赖与simufilam的真实潜力不符 [5] - Cassava并没有一种能够减缓阿尔茨海默病进展的药物 即使是在尝试治疗轻度和中度病例时 [5] - 当真实情况进入市场时 投资者遭受了损失 [5] 律所信息 - 罗森律师事务所专注于证券集体诉讼和股东衍生诉讼 在全球范围内代表投资者 [4] - 该律所曾创下针对中国公司的最大证券集体诉讼和解记录 [4] - 自2013年以来 该律所每年都位列前四 并为投资者追回了数亿美元 [4] - 仅2019年 该律所就为投资者获得了超过4.38亿美元的赔偿 [4] 参与方式 - 投资者可通过指定网站或电话联系Phillip Kim律师加入集体诉讼 [3][6] - 首席原告是代表其他集体成员指导诉讼的代表方 必须在2025年2月10日前向法院提出申请 [3] - 在集体诉讼获得认证前 投资者不会被律师代表 除非自行聘请 [7] - 投资者可以选择自己的律师 也可以选择不作为首席原告 这不会影响其分享未来潜在赔偿的能力 [7]

NEW YORK, Jan. 03, 2025 (GLOBE NEWSWIRE) -- WHY: New York, N.Y., January 3, 2025. Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of Caribou Biosciences, Inc. (NASDAQ: CRBU) between July 14, 2023 and July 16, 2024, both dates inclusive (the “Class Period”). If you wish to serve as lead plaintiff, you must move the Court no later than February 24, 2025. SO WHAT: If you purchased Caribou securities during the Class Period ...

NEW YORK, Jan. 03, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Applied Therapeutics, Inc. (NASDAQ: APLT) between January 3, 2024 and December 2, 2024, both dates inclusive (the “Class Period”), of the important February 18, 2025 lead plaintiff deadline. SO WHAT: If you purchased Applied Therapeutics securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a conti ...

NEW YORK, Jan. 03, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Dentsply Sirona Inc. (NASDAQ: XRAY) between February 28, 2022 and November 6, 2024, both dates inclusive (the “Class Period”), of the important January 27, 2025 lead plaintiff deadline. SO WHAT: If you purchased Dentsply Sirona common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency ...

NEW YORK, Dec. 28, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Customers Bancorp, Inc. (NYSE: CUBI) between March 1, 2024 and August 8, 2024, both dates inclusive (the “Class Period”), of the January 31, 2025 lead plaintiff deadline in the securities class action first filed by the Firm. SO WHAT: If you purchased Customers Bancorp securities during the Class Period you may be entitled to compensation without payment of any out of pock ...

NEW YORK, Dec. 28, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Applied Therapeutics, Inc. (NASDAQ: APLT) between January 3, 2024 and December 2, 2024, both dates inclusive (the “Class Period”), of the important February 18, 2025 lead plaintiff deadline. SO WHAT: If you purchased Applied Therapeutics securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a conti ...

分组1 - ASP Isotopes被指控在2024年10月30日至2024年11月26日期间发布虚假和/或误导性声明 [6][8] - 公司被指控夸大其浓缩技术的潜在有效性 [8] - 公司被指控夸大其高丰度低浓缩铀设施的发展潜力 [8] - 公司被指控夸大其核燃料业务部门的业绩 [8] - 这些行为导致公司关于业务、运营和前景的正面声明被指为误导性和/或缺乏合理依据 [8] 分组2 - 投资者在2024年10月30日至2024年11月26日期间购买ASP Isotopes证券可能有权获得赔偿 [3][6] - 投资者需在2025年2月3日前申请成为首席原告 [6][7] - 首席原告是代表其他集体成员指导诉讼的代表方 [7] 分组3 - Rosen Law Firm是一家全球投资者权益律师事务所，专注于证券集体诉讼和股东衍生诉讼 [4] - 该律所在2017年因证券集体诉讼和解数量排名第一 [4] - 自2013年以来，该律所每年都位列前四，并为投资者追回了数亿美元 [4] - 2019年，该律所为投资者获得了超过4.38亿美元的赔偿 [4]

NEW YORK, Dec. 23, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Xerox Holdings Corporation (NASDAQ: XRX) between January 25, 2024 and October 28, 2024, both dates inclusive (the “Class Period”), of the important January 21, 2025 lead plaintiff deadline. SO WHAT: If you purchased Xerox securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arran ...

NEW YORK, Dec. 23, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Mynaric AG (NASDAQ: MYNA) between June 20, 2024 and October 7, 2024, both dates inclusive (the “Class Period”), of the important December 30, 2024 lead plaintiff deadline. SO WHAT: If you purchased Mynaric securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. WHAT TO ...

NEW YORK, Dec. 14, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Humacyte, Inc. (NASDAQ: HUMA) between May 10, 2024 and October 17, 2024, both dates inclusive (the “Class Period”), of the important January 17, 2025 lead plaintiff deadline. SO WHAT: If you purchased Humacyte securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. WHAT ...